$1.20 Billion in Sales Expected for CME Group Inc. (NASDAQ:CME) This Quarter

Equities research analysts expect CME Group Inc. (NASDAQ:CME) to post sales of $1.20 billion for the current quarter, Zacks reports. Five analysts have made estimates for CME Group’s earnings, with the highest sales estimate coming in at $1.31 billion and the lowest estimate coming in at $1.14 billion. CME Group posted sales of $1.52 billion in the same quarter last year, which would indicate a negative year-over-year growth rate of 21.1%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, May 5th.

According to Zacks, analysts expect that CME Group will report full-year sales of $4.79 billion for the current financial year, with estimates ranging from $4.61 billion to $4.92 billion. For the next fiscal year, analysts forecast that the company will report sales of $5.09 billion, with estimates ranging from $4.87 billion to $5.26 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow CME Group.

CME Group (NASDAQ:CME) last issued its earnings results on Tuesday, February 9th. The financial services provider reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.03. CME Group had a return on equity of 9.22% and a net margin of 43.68%. The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the business earned $1.52 EPS. CME Group’s quarterly revenue was down 3.5% compared to the same quarter last year.

CME has been the topic of a number of recent research reports. JPMorgan Chase & Co. upgraded CME Group from an “underweight” rating to a “neutral” rating and increased their target price for the stock from $138.00 to $203.00 in a report on Thursday, January 7th. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating and set a $205.00 price objective on the stock. in a research note on Thursday, January 7th. Rosenblatt Securities dropped their price objective on CME Group from $140.00 to $135.00 and set a “sell” rating on the stock in a research note on Wednesday, January 6th. Oppenheimer cut CME Group from an “outperform” rating to a “market perform” rating in a research note on Friday, January 15th. They noted that the move was a valuation call. Finally, Barclays raised their price objective on CME Group from $200.00 to $215.00 and gave the company an “overweight” rating in a research note on Tuesday, January 12th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $187.59.

Shares of CME traded up $3.28 during trading hours on Tuesday, reaching $198.75. The stock had a trading volume of 3,453,406 shares, compared to its average volume of 1,840,974. CME Group has a 12 month low of $131.80 and a 12 month high of $225.36. The firm has a 50-day simple moving average of $189.83 and a 200 day simple moving average of $175.15. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $71.35 billion, a price-to-earnings ratio of 32.58 and a beta of 0.46.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 25th. Stockholders of record on Wednesday, March 10th will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.81%. This is a boost from CME Group’s previous quarterly dividend of $0.85. The ex-dividend date is Tuesday, March 9th. CME Group’s payout ratio is presently 50.00%.

In related news, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction dated Friday, February 12th. The stock was sold at an average price of $183.32, for a total value of $183,320.00. Following the completion of the sale, the director now owns 2,565 shares of the company’s stock, valued at approximately $470,215.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 2,300 shares of CME Group stock in a transaction dated Monday, December 21st. The stock was sold at an average price of $182.00, for a total value of $418,600.00. Following the completion of the sale, the insider now directly owns 39,704 shares of the company’s stock, valued at approximately $7,226,128. The disclosure for this sale can be found here. Insiders have sold a total of 13,559 shares of company stock worth $2,450,936 over the last quarter. Company insiders own 1.20% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Avantax Advisory Services Inc. grew its holdings in CME Group by 120.0% during the 3rd quarter. Avantax Advisory Services Inc. now owns 3,830 shares of the financial services provider’s stock valued at $643,000 after buying an additional 2,089 shares in the last quarter. Ascension Asset Management LLC purchased a new position in CME Group during the 3rd quarter valued at about $1,817,000. McGuire Investment Group LLC grew its holdings in CME Group by 0.4% during the 3rd quarter. McGuire Investment Group LLC now owns 48,341 shares of the financial services provider’s stock valued at $8,088,000 after buying an additional 174 shares in the last quarter. Louisiana State Employees Retirement System grew its holdings in CME Group by 18.2% during the 3rd quarter. Louisiana State Employees Retirement System now owns 18,200 shares of the financial services provider’s stock valued at $3,045,000 after buying an additional 2,800 shares in the last quarter. Finally, CWM LLC grew its holdings in CME Group by 2.4% during the 3rd quarter. CWM LLC now owns 2,893 shares of the financial services provider’s stock valued at $484,000 after buying an additional 67 shares in the last quarter. 83.88% of the stock is owned by institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Further Reading: Analyst Ratings Trading

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit